首页|新生儿重症监护病房获得性黏质沙雷菌感染发病的危险因素分析

新生儿重症监护病房获得性黏质沙雷菌感染发病的危险因素分析

扫码查看
目的 分析新生儿重症监护病房(NICU)获得性黏质沙雷菌定植和感染发病危重症患儿的临床特征,探讨造成定植黏质沙雷菌感染发病的危险因素。方法 采用回顾性病例对照研究方法,连续收集2017年1月至2023年12月宁波大学附属妇女儿童医院NICU收治患儿的病例资料。将存在与黏质沙雷菌感染一致的临床体征和(或)症状,并且从标本中分离出黏质沙雷菌的44例患儿作为感染发病组;将同期直肠和(或)咽部培养黏质沙雷菌阳性,但无临床体征和感染症状的45例患儿作为定植对照组。观察黏质沙雷菌感染患儿的细菌分布情况,并对患儿的临床资料进行单因素和二元多因素Logistic回归分析,筛选NICU获得性黏质沙雷菌感染发病的独立危险因素。结果 7年期间NICU共收治患儿5972例,发生医院获得性感染297例,其中44例感染黏质沙雷菌,占医院获得性感染患儿的14。8%;同期检测出黏质沙雷菌定植,但未发病的患儿共45例。定植对照组和感染发病组患儿检测出病原菌部位均以呼吸道为主,分别占86。7%(39/45)和43。2%(19/44)。感染发病组患儿呼吸道感染率最高,占43。2%,其次为血流感染[29。6%(13/44)]、颅内感染[15。9%(7/44)]、肠道感染[6。8%(3/44)]、泌尿道感染[4。5%(2/44)];无死亡病例。定植对照组患儿除呼吸道感染外,还有13。3%(6/45)的患儿存在肠道感染,而无一例患儿在血液、脑脊液和尿液中检出病原菌。单因素分析显示,与定植对照组比较,感染发病组患儿胎龄更小[d:28。5(26。9,30。0)比32。0(30。1,34。6),P<0。01],出生体质量和应用益生菌比例更低[出生体质量(kg):1。20(0。96,1。44)比1。75(1。45,2。23),应用益生菌:29。5%(13/44)比57。8%(26/45),均P<0。01],NICU住院时间和应用抗菌药物时间更长[NICU住院时间(d):65。11±23。00比40。31±20。04,应用抗菌药物时间(d):23。09±9。57比11。80±7。19,均P<0。01],侵入性治疗中机械通气>3 d及中心静脉置管>7 d的比例更高[机械通气>3 d:61。4%(27/44)比20。0%(9/45),中心静脉置管>7 d:81。8%(36/44)比28。9%(13/45),均P<0。01],提示NICU获得性黏质沙雷菌感染发病与以上因素相关。二元多因素Logistic回归分析显示,出生体质量≤1。5 kg[优势比(OR)=5。745,95%可信区间(95%CI)为1。345~24。549,P=0。018]、NICU住院时间>45 d(OR=3。642,95%CI为1。102~12。041,P=0。034)、应用抗菌药物时间(OR=0。871,95%CI为0。799~0。949,P=0。002)、未应用益生菌(OR=3。191,95%CI为1。058~9。627,P=0。039)及侵入性治疗中机械通气>3 d(OR=5。302,95%CI为1。510~18。619,P=0。009)、中心静脉置管>7 d(OR=3。818,95%CI为1。103~13。212,P=0。034)是NICU获得性黏质沙雷菌感染患儿发病的独立危险因素。结论 NICU获得性黏质沙雷菌感染发生率较高;低出生体质量、NICU住院时间延长、长期使用抗菌药物及侵入性治疗是NICU获得性黏质沙雷菌感染发病的独立危险因素;口服益生菌可能是预防NICU获得性黏质沙雷菌感染发病的新方法。
Analysis of risk factors for onset of acquired Serratia marcescens infection in neonatal intensive care unit
Objective To analyze the clinical characteristics of critically ill neonates in the neonatal intensive care unit (NICU) who acquired Serratia marcescens infection for onset or colonization,and to explore the risk factors contributing to the onset of Serratia marcescens infection. Methods A retrospective case-control study was conducted by collecting clinical data from NICU neonates at the Women and Children's Hospital of Ningbo University between January 2017 and December 2023. Forty-four neonates with clinical signs and/or symptoms consistent with Serratia marcescens infection,and with Serratia marcescens isolated from specimens,would be enrolled as the infection onset group,while 45 neonates who tested positive for Serratia marcescens in rectal and/or pharyngeal cultures during the same period,but had no clinical signs or infection symptoms,were enrolled as the colonization control group. The distribution of bacteria in the neonates infected with Serratia marcescens was observed,and clinical data were subjected to univariate and binary multivariate Logistic regression analyses for screening the independent risk factors for onset of acquired Serratia marcescens infection in NICU. Results During the 7-year period,5972 neonates were admitted to the NICU,of which 297 developed hospital-acquired infections. Among these,44 neonates were identified with Serratia marcescens infection,accounting for 14.8% of hospital-acquired infections. During the same period,a total of 45 neonates were diagnosed with the colonization of Serratia marcescens,but did not develop any symptoms. The primary infection sites of the neonates in both the colonization control group and infection onset group were respiratory tract,accounting for 86.7% (39/45) and 43.2% (19/44),respectively. The highest rate of infection in the infection onset group was respiratory tract (43.2%),followed by bloodstream infection[29.6% (13/44)],intracranial infection[15.9%,(7/44)],intestinal infection[6.8% (3/44)],and urinary tract infection[4.5% (2/44)];no deaths were reported. In addition to respiratory tract infection,13.3% (6/45) of the neonates in the colonization control group had intestinal infection,and no pathogenic bacteria was detected in their blood,cerebrospinal fluid,or urine. Univariate analysis showed that compared with the colonization control group,the neonates in the infection onset group had lower gestational ages[days:28.5 (26.9,30.0) vs. 32.0 (30.1,34.6),P<0.01],lower birth weights and proportion of probiotic usage[birth weights (kg):1.20 (0.96,1.44) vs. 1.75 (1.45,2.23),probiotic usage:29.5% (13/44) vs. 57.8% (26/45),both P<0.01],longer length of NICU stay and duration of antibiotic usage[length of NICU stay (days):65.11±23.00 vs. 40.31±20.04,duration of antibiotic usage (days):23.09±9.57 vs. 11.80±7.19,both P<0.01],and higher proportions of invasive procedures such as mechanical ventilation>3 days and central venous catheterization>7 days[mechanical ventilation>3 days:61.4% (27/44) vs. 20.0% (9/45),central venous catheterization>7 days:81.8% (36/44) vs. 28.9% (13/45),both P<0.01],indicating that these factors were associated with Serratia marcescens infection onset acquired in NICU. Binary multivariate Logistic regression analysis showed that a birth weight of ≤ 1.5 kg[odds ratio (OR)=5.745,95% confidence interval (95%CI) was 1.345-24.549,P=0.018],a length of NICU stay>45 days (OR=3.642,95%CI was 1.102-12.041,P=0.034),duration of antibiotic usage (OR=0.871,95%CI was 0.799-0.949,P=0.002),non-usage of probiotics (OR=3.191,95%CI was 1.058-9.627,P=0.039),and invasive procedures such as mechanical ventilation>3 days (OR=5.302,95%CI was 1.510-18.619,P=0.009),and central venous catheterization>7 days (OR=3.818,95%CI was 1.103-13.212,P=0.034) were independent risk factors for the onset of NICU-acquired Serratia marcescens infection. Conclusions The incidence of NICU-acquired Serratia marcescens infection is high. Low birth weight,prolonged length of NICU stay,long-term antibiotic usage,and invasive treatments are independent risk factors for the onset of NICU-acquired Serratia marcescens infection. Oral probiotics may be a new method for preventing onset of NICU-acquired Serratia marcescens infection.

Serratia marcescensNosocomial infectionColonizationRisk factor

李艳红、邱红、杨海银、李莉

展开 >

宁波大学附属妇女儿童医院新生儿重症监护病房,浙江宁波 315012

黏质沙雷菌 医院感染 定植 危险因素

2024

中华危重病急救医学
中华医学会

中华危重病急救医学

CSTPCD北大核心
影响因子:3.049
ISSN:2095-4352
年,卷(期):2024.36(10)